Atlas Trials

Research on the Correlation Between Organoid Drug Sensitivity Testing and Precise Treatment of Gastrointestinal Tumors

Clinical trial NCT06332716 · UNKNOWN

Trial details

NCT number
NCT06332716
Sponsor
Jianjun Yang,MD
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Gastrointestinal Tumors,3D Organoids,Drug Sensitivity
Start date
2022-08-26
Primary completion
2025-12-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.